Catalyst
Slingshot members are tracking this event:
PDUFA Date of June 30th for Tesaro's (TSRO) Niraparib for Patients with Recurrent Ovarian Cancer Following Response to Platinum-Based Chemotherapy
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TSRO |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 27, 2017
Occurred Source:
http://files.shareholder.com/downloads/AMDA-Z6KN1/4127357547x0x934849/52B39B23-4A61-475B-955F-2F9C99645F81/Zejula_FDA_approval_news_release_032417.pdf
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Niraparib, Pdufa, Ovarian Cancer, Platinum-based Chemotherapy
